Agilent Technologies, Inc. (NYSE:A) is Hahn Capital Management LLC’s 5th Largest Position

Hahn Capital Management LLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 33.7% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 47,691 shares of the medical research company’s stock after selling 24,260 shares during the quarter. Agilent Technologies makes up 4.6% of Hahn Capital Management LLC’s holdings, making the stock its 5th largest holding. Hahn Capital Management LLC’s holdings in Agilent Technologies were worth $7,081,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of A. Crewe Advisors LLC increased its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new stake in Agilent Technologies in the third quarter worth $28,000. Ridgewood Investments LLC purchased a new stake in Agilent Technologies in the second quarter worth $29,000. Ashton Thomas Private Wealth LLC purchased a new stake in Agilent Technologies in the second quarter worth $39,000. Finally, Larson Financial Group LLC increased its stake in shares of Agilent Technologies by 29,300.0% during the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after buying an additional 293 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Agilent Technologies Price Performance

Shares of NYSE A opened at $130.72 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78. The company has a market cap of $38.14 billion, a PE ratio of 30.90, a P/E/G ratio of 6.96 and a beta of 1.05. The business has a 50-day simple moving average of $140.91 and a two-hundred day simple moving average of $138.59. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter last year, the company earned $1.43 earnings per share. As a group, equities analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were issued a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares of the company’s stock, valued at $3,497,110. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock worth $1,739,510 over the last quarter. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on A. UBS Group raised their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Bank of America raised their price target on Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI raised their price target on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. Finally, Wells Fargo & Company began coverage on Agilent Technologies in a research note on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $144.36.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.